Savara
Manufacturing · Pennsylvania, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1717 Langhorne Newtown Rd Ste 302, Langh...Phone Number
(512) 614-1848Website
www.savarapharma.comRevenue
$7.8 MillionStock Symbol
SVRAIndustry
About Savara
Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim is delivered via an investigational eFlow® Nebulizer System (PARI Pharma GmbH). Our management team has significant experience in rare respiratory diseases and pulmonary medicine, identifying unmet needs, and effectively advancing product candidates to approval and commercialization.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: SVRAShow moreSavara Org Chart
Compare Similar Companies to Savara
Compare insights from companies similar to Savara, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$95.4M
51-200
Public
$108.5M
1988
KK
Kris KandarpaExecutive Vice President & Chief Medical Officer, Research Development
Savara Tech Stack
A closer look at the technologies used by Savara
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Savara
Sign Up For FreeTo access detailed company insights
Savara is a clinical stage biopharmaceutical company focused on rare respiratory diseases. Our lead program, molgramostim nebulizer solution, is an inhaled granulocyte-macrophage colony-stimulating factor (GM-CSF) in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). Molgramostim is delivered via an investigational eFlow® Neb... Read More
